# US 2025/0085225 A1 · Method for detection of cells by repetitive staining and destaining

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0085225 A1
- Document ID: US20250085225A1
- Status: Published application
- Kind: A1
- Application number: 18/956,170
- Filed: 2024-11-22
- Published: 2025-03-13
- Earliest claimed: 2020-05-27
- Assignees: Miltenyi Biotec GmbH
- Applicants: Miltenyi Biotec B.V. & Co. KG
- Inventors: Jonathan Fauerbach; Christian Dose; Dirk Meineke; Daniel Berndt
- Web page: https://patentgrep.com/patent/US20250085225A1

## CPC

- G01N 33/533: with fluorescent label
- G01N 21/6428: {Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes" (in vivo A61B5/00; immunoassay G01N33/53)}
- G01N 33/5306: {Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding}
- G01N 33/537: with separation of immune complex from unbound antigen or antibody
- G01N 33/542: with steric inhibition or signal modification, e.g. fluorescent quenching
- G01N 33/582: {with fluorescent label}
- G01N 2021/6432: {Quenching}
- G01N 2021/6439: {with indicators, stains, dyes, tags, labels, marks}
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

The invention is directed to a method for detecting a target moiety in a sample of biological specimens by providing a conjugate with the general formula (I) Wherein the fluorescent moiety FL of the labelled target moieties is degraded by irradiating the conjugate with light having a wavelength within the absorbance spectrum of fluorescent moiety FL for a time sufficient to deliver enough energy to reduce the fluorescence radiation emitted by the fluorescent moiety FL at least by 75% of the initial fluorescence radiation.

## Claims

### Claim 1

A method for detecting a target moiety in a sample of biological specimens by providing a conjugate with the general formula (I)
Wherein
G1 and G2 stand for hydrogen, halogen or an antigen recognizing moiety, with the provision that at least one of G1 or G2 is an antigen recognizing moiety,
FL is a fluorescent moiety,
R1, R2, R3, R4, R5, and R6: same or independently selected from the group consisting of H, SO2CF3, SO2Ra, CF3, CCl3, CN, SO3H, NO2, NRaRbRc+, CHO, CORa, CO2Ra, COCl, CONRaRb, F, Cl, Br, I, Ra, ORa, SRa, OCORa, NRaRb, NHCORa, CCRa, (CH2)x, (OCH2CH2)yO(CH2)zCH3, aryl-, heteroaryl-, C6H4ORa or C6H4NRaRb, with Ra, Rb, Rc independently hydrogen, alkyl-, alkenyl-, alkinyl-, heteroalkyl-, aryl-, heteroaryl-, cycloalkyl-, alkylcycloalkyl-, heteroalkylcycloalkyl-, heterocycloalkyl-, aralkyl- or a heteroaralkyl residue, each having 1-100 carbon atoms,
x is an integer from 0 to 20,
y is an integer from 0 to 50, and
z is an integer from 0 to 20,
L is an aryl or a heteroaryl group located on the ends of the polymer,
m is 0.1 to 50 mol %,
n is 50 to 99.9 mol %,
with the proviso that n+m=100 mol %.
p is an integer from 1 to 100, and
q is an integer from 1 to 10,000.
characterized in
a) contacting the sample of biological specimens with at least one conjugate (I), thereby labeling the target moiety recognized by an antigen recognizing moiety with the conjugate (I);
b) exciting the labelled target moieties with light having a wavelength within the absorbance spectrum of the fluorescent moiety FL;
c) detecting the labelled target moieties by detecting the fluorescence radiation emitted by the fluorescent moiety FL and
d) degrading the fluorescent moiety FL of the labelled target moieties by irradiating the conjugate with light having a wavelength within the absorbance spectrum of fluorescent moiety FL for a time sufficient to deliver enough energy to reduce the fluorescence radiation emitted by the fluorescent moiety FL at least by 75% of the initial fluorescence radiation.

### Claim 2 (depends on 1)

The method according to claim 1, characterized in that L is an aryl or a heteroaryl group evenly or randomly distributed along the polymer main chain and is substituted with one or more pendant chains terminated with: i) a functional group selected from amine, carbamate, carboxylic acid, carboxylate, maleimide, activated ester, N-hydroxysuccinimidyl, hydrazine, hydrazide, hydrazine, azide, alkyne, aldehyde, thiol, and protected groups thereof for conjugation to a molecule or biomolecule; or ii) an attached conjugated organic dye as acceptor dye, or iii) a biomolecule.

### Claim 3 (depends on 1)

The method according to claim 1, characterized in that FL is selected from the group consisting of Fluorescein, Fluorescein-Derivatives, Rhodamine, Tetramethylrhodamine, Silicon-Rhodamine (SiR), Coumarines, Resorufines, Pyrenes, Anthracenes, Phenylenes, Phthalocyanines, Cyanines, Xanthenes, Amidopyrylium-Fluorophores, Oxazine, Quadrain-Farbstoffe, Carbopyronine, 7-Nitrobenz-2-Oxa-1,3-Diazol (NBD) Fluorophore, BODIPY™ Fluorophores (Molecular Probes, Inc.), ALEXA™ Fluorophore (Molecular Probes, Inc.), DY™ Fluorophores (Dyomics GmbH), Benzopyrylium Fluorophores, Benzopyrylium-Polymethine Fluorophores, Lanthanid-Chelate, Metalloporhyrines, Rhodol dyes, Carborhodol dyes, Naphthalimides und Porphyrines.

### Claim 4 (depends on 1)

The method according to claim 1, characterized in that G1 and G2 are both independently chosen from the group consisting of hydrogen, halogen or an antigen recognizing moiety at least one is biomolecule selected from the group onsisting of an antibody, an fragmented antibody, an fragmented antibody derivative, peptide/MHC-complexes, receptors for cell adhesion or costimulatory molecules, receptor ligands, antigens, hapten binders, avidin, streptavidin, travidin, aptamers, primers and ligase substrates, peptide/MHC complexe targeting TCR molecules, cell adhesion receptor molecules, receptors for costimulatory molecules or artificial engineered binding molecules.

### Claim 5 (depends on 1)

The method according to claim 1, wherein the fluorescent moiety FL of the labelled target moieties is further degraded by adding oxidative agents.

### Claim 6 (depends on 1)

The method according to claim 1, wherein two residues of R1, R2, R3, R4, R5, and R6 are combined into a cycloalkyl-or heterocycloalkyl ring system as shown in formula II,
Wherin R and R′ stand for the remaining four residues of R1, R2, R3, R4, R5, and R6.

### Claim 7 (depends on 1)

A use of the method of claim 1, in fluorescence microscopy, flow cytometer, fluorescence spectroscopy, cell separation, pathology or histology.
